Nevro Corp (NASDAQ:NVRO) VP Michael Enxing sold 1,500 shares of the business’s stock in a transaction dated Tuesday, October 4th. The shares were sold at an average price of $99.31, for a total value of $148,965.00. Following the transaction, the vice president now owns 39,463 shares in the company, valued at approximately $3,919,070.53. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website.
Michael Enxing also recently made the following trade(s):
- On Thursday, August 4th, Michael Enxing sold 1,500 shares of Nevro Corp stock. The shares were sold at an average price of $82.06, for a total value of $123,090.00.
Shares of Nevro Corp (NASDAQ:NVRO) opened at 100.42 on Tuesday. The firm’s 50-day moving average price is $97.72 and its 200 day moving average price is $79.24. Nevro Corp has a 52-week low of $36.51 and a 52-week high of $106.93. The company’s market capitalization is $2.86 billion.
Nevro Corp (NASDAQ:NVRO) last released its quarterly earnings data on Monday, August 8th. The company reported ($0.31) EPS for the quarter, beating the consensus estimate of ($0.47) by $0.16. The company had revenue of $55.40 million for the quarter, compared to the consensus estimate of $45.11 million. Nevro Corp’s revenue was up 385.5% on a year-over-year basis. On average, equities analysts forecast that Nevro Corp will post ($1.42) earnings per share for the current year.
Several hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Redmile Group LLC increased its position in Nevro Corp by 205.1% in the second quarter. Redmile Group LLC now owns 398,371 shares of the company’s stock valued at $29,384,000 after buying an additional 267,800 shares during the period. Loomis Sayles & Co. L P bought a new position in Nevro Corp during the second quarter valued at approximately $15,047,000. BlackRock Fund Advisors increased its position in Nevro Corp by 45.3% in the second quarter. BlackRock Fund Advisors now owns 646,769 shares of the company’s stock valued at $47,706,000 after buying an additional 201,503 shares during the period. Lord Abbett & CO. LLC increased its position in Nevro Corp by 33.8% in the second quarter. Lord Abbett & CO. LLC now owns 726,817 shares of the company’s stock valued at $53,610,000 after buying an additional 183,441 shares during the period. Finally, American Century Companies Inc. increased its position in Nevro Corp by 209.1% in the second quarter. American Century Companies Inc. now owns 243,184 shares of the company’s stock valued at $17,937,000 after buying an additional 164,505 shares during the period.
A number of research analysts recently issued reports on the company. Zacks Investment Research upgraded Nevro Corp from a “hold” rating to a “buy” rating and set a $110.00 price target on the stock in a report on Wednesday, October 5th. B. Riley assumed coverage on Nevro Corp in a report on Wednesday, September 21st. They set a “buy” rating and a $114.00 price target on the stock. Piper Jaffray Cos. restated an “overweight” rating and set a $112.00 price target (up previously from $98.00) on shares of Nevro Corp in a report on Thursday, August 11th. JMP Securities boosted their price target on Nevro Corp from $90.00 to $110.00 and gave the company a “market outperform” rating in a report on Tuesday, August 9th. Finally, JPMorgan Chase & Co. boosted their price target on Nevro Corp from $84.00 to $100.00 and gave the company an “overweight” rating in a report on Tuesday, August 9th. Eleven equities research analysts have rated the stock with a buy rating, The company presently has an average rating of “Buy” and an average price target of $104.00.
About Nevro Corp
Nevro Corp. is a medical device company. The Company has developed and commercialized a neuromodulation platform for the treatment of chronic pain. The Company’s Senza system is a spinal cord stimulation (SCS) system that delivers its HF10 therapy. HF10 therapy is designed to deliver neuromodulation solutions for treating chronic pain.
Receive News & Ratings for Nevro Corp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nevro Corp and related companies with MarketBeat.com's FREE daily email newsletter.